By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fox Chase Cancer Center in Philadelphia said today that it will partner with Life Technologies to develop, use, and evaluate the use of next-generation clinical sequencing technologies for personalized cancer care.

The partnership will be a cornerstone for the planned Cancer Genome Institute at Fox Chase, which aims to combine multidisciplinary resources at the center to evaluate how genomic sequencing of tumors can be used to manage cancer patients.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.